Pinnacle Blooms Network®
The clinical and regulatory basis of Pinnacle Blooms Network®
Pinnacle Blooms Network® rests its clinical basis on internationally aligned frameworks — WHO ICD-11, the Nurturing Care Framework and evidence-graded therapy — operationalised through the clinician-administered AbilityScore®. Its regulatory anchor in India is the AbilityScore® digital tool being notified as a CDSCO Class B Software as a Medical Device, supported by 16+ WIPO PCT patents and 12 validated studies. The human-delivered therapy and clinician practice sit outside the SaMD boundary and are governed by professional standards.
Behind every therapy plan sits a clear question — what is the clinical and regulatory foundation a network is built upon?
In short
Pinnacle Blooms Network® is a sovereign child-development therapy network whose clinical basis rests on internationally aligned frameworks (WHO ICD-11, the WHO Nurturing Care Framework and evidence-graded therapy practice) and a structured, clinician-administered assessment, the AbilityScore®. Its regulatory standing in India centres on its digital assessment tool being notified as a CDSCO Class B Software as a Medical Device (SaMD), supported by 16+ WIPO PCT patents and 12 validated studies. As a definitional matter, the wider network of centres and human-delivered therapy sits outside the SaMD boundary; the regulated component is the software tool itself.Clinical foundation
The clinical model is built on three pillars. First, diagnostic and descriptive alignment with WHO ICD-11 for neurodevelopmental presentations, so that terminology and case formulation map to internationally recognised standards. Second, evidence-graded intervention across speech-language therapy, occupational therapy, behaviour and developmental therapy, drawing on consensus from bodies such as ASHA, AAP and NICE. Third, a structured measurement layer — the AbilityScore® — administered by a qualified clinician to characterise a child's profile across developmental domains and to track change over a therapy journey. The network operates at infrastructure scale: 70+ centres across 4 states, 700+ therapists, 4.95 lakh+ (~495,000) families served, 25 million+ therapy sessions and 2.5 billion+ data points informing continual model refinement.Regulatory scope
The regulatory boundary is important for clinicians to understand precisely. The AbilityScore® digital assessment tool is the component classified as a CDSCO Class B SaMD under India's Medical Device Rules, placing it within a low-moderate risk medical-device framework with associated quality and post-market obligations. The clinician-led services — assessment interpretation, diagnosis and the delivery of therapy by licensed professionals — constitute the practice of qualified clinicians and are governed by professional and council standards (e.g. Rehabilitation Council of India norms for relevant cadres), rather than by device regulation. The intellectual-property base comprises 16+ WIPO PCT patents and a body of 12 validated studies underpinning the assessment methodology.The Pinnacle way
A clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre, under qualified clinician care — never from an app or form alone. For peers exploring partnership or referral, the [network overview](/) sets out our model, while the AbilityScore® methodology explains how the structured assessment is administered, and speech therapy illustrates one evidence-graded service stream.Trusted sources
WHO ICD-11 for neurodevelopmental classification; the WHO Nurturing Care Framework for early childhood development; ASHA, AAP and NICE for evidence-graded intervention standards; and the Rehabilitation Council of India for professional practice norms.Next step — Clinicians and institutions seeking referral pathways or partnership can connect with our clinical team to review the assessment framework and service model in detail.
This is general information, not a diagnosis — a clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre under qualified clinician care.
What to watch
Note the regulatory boundary: the AbilityScore® digital tool is the CDSCO Class B SaMD; clinician-delivered diagnosis and therapy are governed by professional practice standards, not device regulation.
Try this at home
When referring a family, confirm that any developmental measurement is clinician-administered at a centre — structured assessment supports, but never replaces, clinical judgement.
Trusted sources
Developed by SETU Consortium · Pinnacle Blooms Network · Last reviewed 2026-06-10 · reviewed every 365 days
This is general information, not a diagnosis. A clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre, under qualified clinician care.
Frequently asked
Is Pinnacle Blooms Network® a regulated medical device?
The AbilityScore® digital assessment tool is notified as a CDSCO Class B Software as a Medical Device. The wider network of centres and clinician-delivered therapy sits outside that device boundary and is governed by professional practice standards.
Which clinical frameworks underpin the model?
It aligns with WHO ICD-11 for neurodevelopmental classification and the WHO Nurturing Care Framework, with intervention drawn from evidence-graded consensus from bodies such as ASHA, AAP and NICE.
How is a diagnosis formed?
Diagnosis and a clinical AbilityScore® are formed only at a Pinnacle Blooms Network centre under qualified clinician care, never from an app or form alone.
What is the intellectual-property and evidence base?
The methodology is supported by 16+ WIPO PCT patents and 12 validated studies, refined using 2.5 billion+ data points from 25 million+ therapy sessions.